MAPT and Alzheimer disease: Whereas others reported (moderate) associations between larger increases in tau pathology and larger decreases in cortical thickness in individuals with mild cognitive impairment or atypical AD [12, 13], we found no associations surviving correction for multiple testing between change in tau pathology and longitudinal cortical thickness.